Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) shares traded 3.11% higher at $0.63 on Wall Street last session.
CDIO stock price is now -3.05% away from the 50-day moving average and 14.54% away from the 200-day moving average. The market capitalization of the company currently stands at $25.35M.
In other news, Philibert Robert, Chief Medical Officer bought 34,075 shares of the company’s stock on Sep 06 ’24. The stock was bought for $9,763 at an average price of $0.29. Upon completion of the transaction, the Chief Medical Officer now directly owns 1,683,867 shares in the company, valued at $1.06 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 06 ’24, Chief Technology Officer Dogan Meeshanthini bought 68,965 shares of the business’s stock. A total of $20,000 was incurred on buying the stock at an average price of $0.29. This leaves the insider owning 197,310 shares of the company worth $0.12 million. A total of 9.73% of the company’s stock is owned by insiders.
During the past 12 months, Cardio Diagnostics Holdings Inc has had a low of $0.19 and a high of $2.40. As of last week, the company has a debt-to-equity ratio of 0.20, a current ratio of 8.51, and a quick ratio of 8.51. The fifty day moving average price for CDIO is $0.64132 and a two-hundred day moving average price translates $0.550265 for the stock.
The latest earnings results from Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) was released for 2024-06-30. The net profit margin was -23125.63% and return on equity was -276.30% for CDIO. The company reported revenue of $7000.0 for the quarter, compared to $10000.0 a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -30.0 percent.
